CORZ 8-K: Q3 2025 results press release furnished (Items 2.02, 7.01)

Rhea-AI Filing Summary

Core Scientific (CORZ) furnished a press release announcing its financial results for the third quarter ended September 30, 2025. The press release is included as Exhibit 99.1 under Item 2.02, with related disclosure under Item 7.01. These materials are furnished and not deemed filed under the Exchange Act.

8-K Event Classification

3 items: 2.02, 7.01, 9.01

3 items

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Understanding 8-K Material Events →

0001839341FALSECore Scientific, Inc./tx838 Walker RoadSuite 21-2105DoverDelaware00018393412025-10-242025-10-240001839341us-gaap:CommonStockMember2025-10-242025-10-240001839341core:WarrantExercisePriceOf6.81PerShareMember2025-10-242025-10-240001839341core:WarrantExercisePriceOf0.01PerShareMember2025-10-242025-10-24

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 24, 2025

Core Scientific, Inc.

(Exact name of registrant as specified in its charter)

Delaware

001-40046

86-1243837

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification No.)

838 Walker Road, Suite 21-2105 Dover, Delaware						19904
(Address of principal executive offices)						(Zip Code)

Registrant’s telephone number, including area code: (512) 402-5233

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common stock, par value $0.00001 per share			CORZ			The Nasdaq Global Select Market
Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $6.81 per share			CORZW			The Nasdaq Global Select Market
Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $0.01 per share			CORZZ			The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02    Results of Operations and Financial Condition

On October 24, 2025, the Company issued a press release announcing its financial results for the third fiscal quarter ended September 30, 2025. A copy of the press release is furnished hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 7.01    Regulation FD Disclosure

The information contained in Item 2.02 is incorporated herein by reference.

The information in Items 2.02 and 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

Item 9.01    Financial Statement and Exhibits

(d) Exhibits:

Exhibit No.						Description
99.1						Press Release dated October 24, 2025
104						Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			Core Scientific, Inc.
Dated: October 24, 2025
			By:			/s/ Todd M. DuChene
			Name:			Todd M. DuChene
			Title:			Chief Legal Officer and Chief Administrative Officer

FAQ

What did Core Scientific (CORZ) disclose in this 8-K?

It furnished a press release announcing financial results for the quarter ended September 30, 2025, attached as Exhibit 99.1.

Which items are covered in the 8-K for CORZ?

The report includes Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure).

Is the information in the 8-K considered filed or furnished?

The information in Items 2.02 and 7.01, including Exhibit 99.1, is furnished and not deemed filed under the Exchange Act.

What is the date of the earliest event reported for CORZ?

The earliest event date is October 24, 2025.

What securities and tickers are listed for Core Scientific?

Common stock: CORZ. Warrants: CORZW (exercise price $6.81 per share) and CORZZ (exercise price $0.01 per share), each on Nasdaq.

Where can investors find the Q3 2025 results details?

In the press release furnished as Exhibit 99.1 to this 8-K.